These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 26949933)

  • 1. Drug-induced Raynaud's phenomenon: beyond β-adrenoceptor blockers.
    Khouri C; Blaise S; Carpentier P; Villier C; Cracowski JL; Roustit M
    Br J Clin Pharmacol; 2016 Jul; 82(1):6-16. PubMed ID: 26949933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium channel blockers for primary and secondary Raynaud's phenomenon.
    Rirash F; Tingey PC; Harding SE; Maxwell LJ; Tanjong Ghogomu E; Wells GA; Tugwell P; Pope J
    Cochrane Database Syst Rev; 2017 Dec; 12(12):CD000467. PubMed ID: 29237099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacology of Raynaud's phenomenon].
    Roustit M; Khouri C; Blaise S; Villier C; Carpentier P; Cracowski JL
    Therapie; 2014; 69(2):115-28. PubMed ID: 24926630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Calcium antagonists and Raynaud's phenomenon].
    Hachulla E; Devulder B
    Therapie; 1993; 48 Spec No():707-11. PubMed ID: 8091357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral vasoconstriction induced by β-adrenoceptor blockers: a systematic review and a network meta-analysis.
    Khouri C; Jouve T; Blaise S; Carpentier P; Cracowski JL; Roustit M
    Br J Clin Pharmacol; 2016 Aug; 82(2):549-60. PubMed ID: 27085011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of beta-adrenoceptor antagonists on prevalence of peripheral vascular symptoms in hypertensive patients.
    Steiner JA; Cooper R; McPherson K; Riley AJ
    Br J Clin Pharmacol; 1982 Dec; 14(6):833-7. PubMed ID: 6129884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Raynaud's phenomenon as side effect of beta-blockers in hypertension.
    Marshall AJ; Roberts CJ; Barritt DW
    Br Med J; 1976 Jun; 1(6024):1498-9. PubMed ID: 6109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Letter: Raynaud's phenomenon as side effect of beta-blockers.
    Marshall A; Barritt DW; Roberts CJ
    Br Med J; 1976 Jul; 2(6030):301. PubMed ID: 8186
    [No Abstract]   [Full Text] [Related]  

  • 9. Raynaud's phenomenon and digital ischaemia--pharmacologic approach and alternative treatment options.
    Linnemann B; Erbe M
    Vasa; 2016; 45(3):201-12. PubMed ID: 27129065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Raynaud's phenomenon after chemotherapy. Apropos of 3 cases].
    Adoue D; Arlet P; Vilain C; Le Tallec Y; Bonafé JL; de Lafontan B
    Ann Dermatol Venereol; 1985; 112(2):151-5. PubMed ID: 2408534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laser Doppler-recorded venoarteriolar reflex in Raynaud's phenomenon.
    Stoyneva Z
    Auton Neurosci; 2004 Nov; 116(1-2):62-8. PubMed ID: 15556839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The diagnosis and treatment of Raynaud's phenomenon: a practical approach.
    Pope JE
    Drugs; 2007; 67(4):517-25. PubMed ID: 17352512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium channel blockers for primary Raynaud's phenomenon.
    Ennis H; Anderson ME; Wilkinson J; Herrick AL
    Cochrane Database Syst Rev; 2014 Jan; (1):CD002069. PubMed ID: 24482037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of digital artery adrenoceptors in Raynaud's disease.
    Cooke JP; Creager SJ; Scales KM; Ren C; Tsapatsaris NP; Beetham WP; Creager MA
    Vasc Med; 1997; 2(1):1-7. PubMed ID: 9546943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Methylphenidate and secondary Raynaud's phenomenon].
    Iglesias Otero M; Portela Romero M; Bugarín González R; Ventura Victoria MA
    Semergen; 2013 Sep; 39(6):330-4. PubMed ID: 24034762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Raynaud's phenomenon: a common toxicity after combination chemotherapy for testicular cancer.
    Vogelzang NJ; Bosl GJ; Johnson K; Kennedy BJ
    Ann Intern Med; 1981 Sep; 95(3):288-92. PubMed ID: 6168223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical relevance of Raynaud's phenomenon symptom characteristics in systemic sclerosis.
    Hughes M; Huang S; Pauling JD; Sabbagh M; Khanna D
    Clin Rheumatol; 2022 Oct; 41(10):3049-3054. PubMed ID: 35583625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Digital blood flow response to body warming, cooling, and rewarming in patients with Raynaud's phenomenon.
    Lau CS; Khan F; Brown R; McCallum P; Belch JJ
    Angiology; 1995 Jan; 46(1):1-10. PubMed ID: 7818151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding, assessing and treating Raynaud's phenomenon.
    Boin F; Wigley FM
    Curr Opin Rheumatol; 2005 Nov; 17(6):752-60. PubMed ID: 16224254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of Raynaud's disease.
    Cooke JP; Marshall JM
    Vasc Med; 2005 Nov; 10(4):293-307. PubMed ID: 16444858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.